Evidence map›Paper›PMID 35505163›Full record

ArticleAdvances in experimental medicine and biology2022

Gadd45 Proteins in Immunity 2.0.

Ingo Schmitz

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Salubrious effects of proanthocyanidins on behavioral phenotypes and DNA repair deficiency in the BTBR mouse model of autism.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  5. Review
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ingo SchmitzDepartment of Molecular Immunology, Ruhr University Bochum, Bochum, Germany. ingo.schmitz@ruhr-uni-bochum.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To protect the host against invading pathogens such as viruses, bacteria, and parasites as well as against tumor cells, the immune system of vertebrates has to distinguish between self and non-self, but also between harmless and dangerous. To do so, the immune system developed an innate and an adaptive branch that provide immediate and long-lasting protection, respectively. Furthermore, the immune system is composed of different cell types, which are specialized to combat different threats, and it is located at strategic locations to manage surveillance of the whole body. Therefore, immune cells need to communicate with each other. Growth arrest and DNA damage-inducible 45 (Gadd45) proteins are important components of intracellular signaling networks that convey messages from other cells in the receiving cell into biological responses. Within the 7 years that have passed since my first overview about Gadd45 proteins in the immune system, substantial progress has been made in our understanding of the immune system and with respect to Gadd45 proteins. Therefore, it is time for an update-Gadd45 proteins in immunity 2.0. In order to put Gadd45 proteins into the context of the immune system, I will first give a brief introduction into the immune system. Afterwards, I will give a brief introduction into Gadd45 proteins. For deeper insight, I refer to the other chapters of this book. The third section discusses the role of Gadd45 proteins in myeloid and lymphoid cells. The last two sections will be on the function of Gadd45 proteins in infection, autoimmunity, and tumor immunology.

Indexed as

ProteinsSignal TransductionAnimalsAutoimmunityDNA DamageProteinsAutoimmunityAutophagyGADD45ImmunityInfectionLymphoid cellsMyeloid cellsTumor immunology

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.